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Abstract The 5-year survival rate for colorectal cancer is
approximately 55 % because of its invasion and metastasis.
The epithelial–mesenchymal transition (EMT) is one of the
well-defined processes during the invasion and distant
metastasis of primary epithelial tumors. miR-429, a mem-
ber of the miR-200 family of microRNAs, was previously
shown to inhibit the expression of transcriptional repressors
ZEB1/delta EF1 and SIP1/ZEB2, and regulate EMT. In this
study, we showed that miR-429 was significantly down-
regulated in colorectal carcinoma (CRC) tissues and cell
lines. We found that miR-429 inhibited the proliferation
and growth of CRC cells in vitro and in vivo, suggesting
that miR-429 could play a role in CRC tumorigenesis. We
also showed that downregulation of miR-429 may con-
tribute to carcinogenesis and the initiation of EMT of CRC
by targeting Onecut2. Further researches indicated that
miR-429 inhibited the cells migration and invasion and
reversed TGF-b-induced EMT changes in SW620 and
SW480 cells. miR-429 could reverse the change of EMT-
related markers genes induced by TGF-b1, such as
E-cadherin, CTNNA1, CTNNB1, TFN, CD44, MMP2,
Vimentin, Slug, Snail, and ZEB2 by targeting Onecut2.
Taken together, our data showed that transcript factor
Onecut2 is involved in the EMT, migration and invasion of
CRC cells; miR-429 inhibits the initiation of EMT and
regulated expression of EMT-related markers by targeting
Onecut2; and miR-429 or Onecut2 is the important therapy
target for CRC.
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Introduction
Colorectal cancer (CRC) is one of the most common gas-
trointestinal malignant tumors in the world and the third
leading cause of cancer death worldwide [1]. There are
about 1.2 million new-onset patients around the world each
year, and about half of them die within 5 years, and
invasion and metastasis is the leading cause of death of
patients with CRC [2]. Tumor invasion and metastasis is a
complicated process involving in various factors and
multiple steps. One of the well-defined processes that
occurred during the invasion and distant metastasis of
primary epithelial tumors is called the epithelial–mesen-
chymal transition (EMT) which was commonly observed in
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various types of malignant tumors including CRC [3, 4]. A
number of studies have indicated that growth factors, such
as transforming growth factor-b (TGF-b), epithelial growth
factor (EGF), hepatocyte growth factor (HGF), insulin-like
growth factor (IGF), vascular endothelial growth factor
(VEGF), and platelet-derived growth factor (PDGF) are the
activators of EMT [5, 6].
TGF-b/Smad signaling pathway; mitogen-activated pro-
tein kinase (the mitogen-activated protein kinase MAPK)
signaling pathway; Src kinase signaling pathway; the Rho
kinase pathway; phosphatidylinositol-3 kinase (phosphati-
dylinositol 3 kinase, PI3K) signaling pathway; Jagged1/Notch
signaling pathway; the Wnt/b-catenin signaling pathway; and
other cell proliferation, apoptosis, metastasis-related signal-
ing pathways have been involved in the initiation of EMT, and
these pathways have the rich cross-talk in the EMT process
[7–10]. Studies have confirmed that many transcription fac-
tors including Twist, Snail, Slug, ZEB1, ZEB2, E27, FOXC2,
Goosecoid, and NF-jB are the activators of EMT, and play an
important role in tumor metastasis [11–16]. Recent studies
have identified microRNAs as key players in EMT-associated
cancer metastasis. For example, miR-1 and miR-200 inhibit
EMT and tumorigenesis via Slug-independent mechanisms
[17]. miR203/Snail-1 and miR200/ZEB construct two fun-
damental negative feedback loops of EMT core network [18].
The members of the miRNA-200 family (miR-141; miR-
200a, b, c; and miR-429) and miR-205 play important roles in
the EMT-associated cancer metastasis [19–22]. ZEB1 and
ZEB2 are known targets of miRNA-200 family and inhibition
of these regulating microRNAs has been shown to be suffi-
cient to induce EMT in a variety of cell types [23].
On the basis of miRNA–RNA network of CRC con-
structed by our previous research, we found that miR-429,
miR-18, and miR-490-3p are the core of the target genes
network [24]. miR-429, a member of the miR-200 family
of microRNAs, was previously shown to inhibit the
expression of transcriptional repressors ZEB1/delta EF1
and SIP1/ZEB2 and regulate EMT, which represents an
important early step during metastasis [25]. We, thus,
proposed that the deregulation of miR-429 would influence
the pathological progress of CRC. Validation of miR-429
with expression in extended clinical sample and cell biol-
ogy functional assay proved our hypothesis that miR-429
would act as an anti-EMT and invasion miRNA.
Materials and methods
Patients and tissue samples
The patient material including primary tumor (II and III
stages) and the corresponding adjacent normal tissue
(paracancerous tissues) were collected at the Xiangya
Affiliated Hospital, Xiangya Second and Third Affiliated
Hospital, Central South University between the years 2009
and 2011. Written informed consent was obtained from all
the study participants. Collections and using of tissue
samples were approved by the ethical review committees
of the Xiangya Hospital Ethic Committee of Central South
University.
Cell lines and cell culture
Human colorectal carcinoma cell lines SW-480, SW-620,
and HT-29 were obtained from the Cell Bank of Shanghai
(China) and were cultured in RPMI 1640 medium supple-
mented with 10 % fetal calf serum, 100 U/ml penicillin, and
100 lg/ml streptomycin at 37 in a 5 % CO2 incubator. TGF-
b1-stimulation experiments were performed with recombi-
nant human TGF-b1 (10 ng/ml; RD systems).
Real-time quantitative PCR analysis
The total RNAs were extracted from cells with TRIZOL
reagent (Invitrogen, Wuhan, China). RT reactions were per-
formed by means of SYBR-green-containing PCR kit
(GenePharma, Shanghai, China).The primers for real-time
PCR to detect miR-429 (Forward primer: 50-UA-
AUACUGUCUGGUAAAACCGU-30; Reverse primer: 50-
UUCUCCGAACGUGUCACGUTT-30) were designed based
on the miRNA sequences provided by the Sanger Center
miRNA Registry and were synthesized and purified by
Shanghai Gene-Pharma biotechnology limited company
(Shanghai, China). The primers of EMT-related marker genes
were synthesized and purified by Shanghai Shengong Bio-
technology Limited Company (Shanghai, China). All real-
time PCR were performed on the BIO-RAD IQTM5 Multi-
color Real-Time PCR detection System (Bio-Rad, USA).
The primers of EMT-related marker genes
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Table a continued














In situ hybridization and immunochemistry analysis
miR-429 miRCURYTM LNA custom detection probe
(Exiqon, Vedbaek, Denmark) was used for in situ hybrid-
ization (ISH). The sequence 50–30 (enhanced with LNA)
was acggttttaccagacagtatta with DIG at the 50 and 30 ends.
Hybridization, washing, and scanning were carried out
according to the manuals and protocols provided by the
Exiqon life science department. Immunohistochemistry
(IHC) studies were performed using the standard strepta-
vidin/peroxidase staining method as described previously.
Image analysis and total gray value were estimated by the
GSM-2000P pathology image analysis system [26].
MTT assays
Logarithmically growing SW-480, SW-620, and HT-29
cells were seeded in 96-well plates (5 9 103 cells/100 ll
medium/well) for 6 h. The culture medium was replaced
after 24 h with fresh medium containing different con-
centrations (2.5, 5.0, and 7.5 qM) of miR-429 mimics.
Cells were incubated in the presence of the mimics for 24,
36, 48, 60, and 72 h and then incubated for 4 h in the
presence of 20 ll MTT solution (5 g/l, Sigma, Beijing,
China). DMSO was added (100 ll/well) and OD values at
490 nm were recorded with the ELX 800 absorbance
Microplate Reader (BioTak, Winooski, VT), scramble was
used as the control. The assay was performed three times
with eight replicates.
Luciferase assays
The 30-untranslated regions (UTRs) of the Onecut2 gene
were synthesized and annealed, then inserted into the
pMIR-REPORT(TM) Luciferase vector (Ambion), using
the Hind III (aagctt) and Spe I (actagt) site downstream
from the stop codon of luciferase (Luc-wt). We also gen-
erated an insert with deletions of 4 bp from the site of
perfect complementarity of the Onecut2 gene (Luc-mut).
pMIR-Onecut2-wt:
Forward primer: 50-CTAGTTATTATGGGTACTT









Luc-wt or Luc-mut was cotransfected with miR-429
mimics into CRC cells. The pMIR-REPORTTM–b galac-
tosidase control vector was transfected as a control.
Luciferase activity was measured in cell lysates 48 h after
transfection using the Dual-Light luminescent reporter
gene assay kit (Applied Biosystems). The pMIR-
REPORTTM–b-gal control vector was cotransfected as an
internal control to correct the differences in both trans-
fection and harvest efficiencies. Transfections were done in
duplicates and repeated at least thrice in independent
experiments.
Western blot
Western blot was performed as previously described [4].
Rabbit polyclonal primary antibody against Onecut2 and
mouse monoclonal antibody GAPDH was purchased from
Cell Signaling Technology (Beverly, MA, USA) and Santa
Cruz Biotechnology Inc., (Santa Cruz, CA).
Construction of pcDNA3.1–Onecut2 plasmids
Briefly, the full length of Onecut2 gene which was
amplified by PCR was linked into pcDNA3.1 vector. The
primer was designed by primer 3 software. Forward pri-
mer: 50-CACTTGGCAGACCTCTCCTC-30; Reverse pri-
mer: 50-ACTGTATGGAGGCCCA GTTGTCT-30
Wound-healing assay
CRC cells seeded in 6-well plates to be long to near sat-
uration and were ‘‘wounded’’ by removing a line of cells
with disinfected Eppendorf Tip. After washing with FBS-
free medium, the wound areas were photographed under a
microscope. The cells were treated in triplicate with 20 ng/
ml TGF-b in FBS-starved medium. Their migrations were
monitored at 24- and 48-h post-treatment.
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Matrigel chamber invasion assay
The diluted matrigel (BD Biosciences) was added to the upper
well of the Transwell chamber (Corning Inc., Corning, NY), and
reconstituted for 1 h at 37 C. The cells were starved overnight
in serum-free medium and re-suspended at a concentration of
2.5 9 105 cells/ml in serum-free medium containing 0.1 %
bovine serum albumin. 0.2 ml cell suspension was added to the
top of each well, and a 10 mg/ml fibronectin solution was added
to the bottom well of the chamber as a chemoattractant. After
36 h, the cells that had not invaded were removed from the
upper surface of the filters using a cotton swab. The cells that
had invaded to the lower surface of the filter were fixed with
methanol, stained with H&E, and 5 random fields (409) were
counted. The data were expressed as the mean value of cells per
field in triplicate in two independent experiments.
Tumor formation assay in nude mice
Cells were washed once with PBS and subcutaneously injected
into the flank region at a concentration of 2 9 107 cells/mouse
(5-week-old male nude mice). 10 mice were randomly divided
into two groups (n = 5). Aliquots of 40 ll of PBS containing
1 lg of mature miR-429 or scramble were directly injected into
the tumor. At the end of each study, animals were sacrificed and
tumors were collected and divided for either storage in RNA
later (TaKaRa Inc., Dalian, China) following the manufac-
turer’s instructions for the following RNA extraction, or fixed in
formalin for ISH and IHC. Image analysis and total gray value
were estimated by the GSM-2000P pathology image analysis
system (Heima Zhuhai, China). Tumor growth was monitored
by caliper measurement once or twice a week for at least
5 weeks. Tumor volume was calculated as follows:
V = L 9 l2 9 0.5, where L and l represent the larger and the
smaller tumor diameters, respectively. The animal experiments
were performed in accordance with the institutional guidelines.
Statistical analysis
Differences between groups were tested by a Student’s t test
or one-way analysis of variance (ANOVA) using the SPSS
13.0 program (SPSS, Inc., Chicago, IL, USA). Spearman’s
correlation test was used to evaluate the pairwise expression
correlation between miR-429 and Onecut2 in CRC.
Results
miR-429 inhibits proliferation and tumorigenesis
in CRC cell
In order to evaluate the anti-proliferation and anti-tumori-
genesis of miR-429, in vitro and in vivo experiments were
carried out. The expression of miR-429 was validated by
real-time PCR in both CRC tissues and cell lines. miR-429
is significantly downregulated in both II and III stage CRC
tissues and cell lines compared to that of the corresponding
adjacent normal colon mucosa (P \ 0.01) (Fig. 1a). The
anti-proliferative effect of miR-429 was evaluated in CRC
cell lines including SW480, SW620, and HT-29 which
were transfected with miR-429 mimics and scramble con-
trol in dose (2.5, 5.0, and 7.5 pm) and time (24, 36, 48, 60,
and 72 h). The transfection of miR-429 is successful
(Fig. 1a). Although MTT measurement did not show a
significant dosage effect (P [ 0.05) (Fig. 1b), it is obvious
to notice the significant anti-proliferative effect of miR-429
mimics especially at 72 h of transfection comparing to the
scramble-treated cells (Fig. 1b). Thus, we selected the least
concentrations of 2.5 pm and 72 h as the standard trans-
fection protocol in the further studies.
Encouraged by the results in vitro, we took a further step
toward the assessment of the feasibility of the direct in vivo
miR-429 treatment. Highly metastatic potential CRC cell
line SW620 was subcutaneously injected into both the
flanks of nude mice in order to yield tumors that were then
treated by direct intratumoral injection as soon as they
became clearly palpable. For each mouse, the tumor on one
flank was injected with miR-429, while the control lateral
tumor was injected with a control scramble. The growth
curves of miR-429-treated versus scramble-treated tumors
are compared in Fig. 1c. As shown, the two curves slowly
become divergent until they reach statistically different
values at 17 days after the first day of injection (Student’s
t test, P \ 0.05). In accordance with this observation, the
average weight of the treated tumors at the end of the
experiment was significantly reduced as compared to that
of the control tumors (Student’s t test, P \ 0.01).
miR-429 targets ONECUT2 and decreases its
expression in CRC cells and tissues
ONECUT2 is a member of the ONECUT transcription
factor family, which was showed to be the core of the
microRNA–gene networks by our previous study [24] and
we proposed that ONECUT2 is one of the crucial targets of
miR-429. To demonstrate this in CRC cells, the ONECUT2
complementary sequence or the mutant with a deletion of 4
nucleotides for the predicted binding of the miR-429 were
cloned downstream of the firefly luciferase gene. SW620
cells were cotransfected with firefly luciferase constructs
containing the ONECUT2 wild-type or mutated 30UTRs
and miR-429 or scramble oligonucleotides for 24 h,
respectively. Luciferase activities were measured, as
shown in Fig. 2a; significantly reduced luciferase activity
was detected in cell transfected with wild-type ONECUT2
and miR-429, compared with the mutant sequence,
22 Mol Cell Biochem (2014) 390:19–30
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indicating that the ONECUT2 complementary sequence
contained the binding site for miR-429. The repressive
effect of miR-429 on ONECUT2 expression was also
measured in CRC cell lines HT-29, SW620, and SW480 by
both real-time PCR and Western blot. As shown in Fig. 2b,
c, miR-429 significantly reduced the expression of ONE-
CUT2 in both transcriptional and protein level, respec-
tively, which confirmed our previous bioinformatics
prediction of the repressive effect of miR-429 on ONE-
CUT2 expression.
We further confirmed that there was an inverse corre-
lation between miR-429 levels and Onecut2 mRNA levels
by real-time PCR in 50 CRC and 50 paracancerous normal
tissue specimens (Fig. 2d). At the same time, we also used
the CRC tissue array [24] to detect the expression of miR-
429 by ISH and Onecut2 by IHC staining, and the results
showed that miR-429 existed in cytoplasm and its
expression was significantly decreased in CRC relative to
paracancerous normal tissues; Onecut2 existed in nucleus
and its expression was significantly increased in CRC rel-
ative to paracancerous normal tissues (Fig. 2e).
The above data suggest that downregulation of miR-429
contributes to CRC carcinogenesis by targeting regulating
transcript factor Onecut2.
Effect of miR-429 on cells mobility and invasion
by target Onecut2 in CRC cells
The previous research indicated that although deregulation
of miR-429 was not correlated with the lymphatic metas-
tasis [24], miR-429 may be involved in the initiation of
invasion of CRC. In light of the above findings, we decided
to explore the biological significance of miR-429 in CRC
tumorigenesis. Wound-healing assay was used to detect the
impact of miR-429 on cell motility. SW620 cells were
transfected with miR-429 mimics and the scramble control
mimics, the wound healing was observed in an inverted
microscope after scratching 0 and 24 h. After scratching
Fig. 1 miR-429 inhibits
proliferation and tumorigenesis
in CRC cells. a miR-429
downregulated expression in the
CRC tissues (10 cases II and III
stage CRC tissues and 10 cases
corresponding to the adjacent
normal tissue) and multiple cell
lines (HT-29, SW620, and
SW480 cell). **P \ 0.01
compared to the expression of
CRC tissues. b miR-429
inhibited the cell proliferation of
CRC cells for different times
in vitro. c miR-429 attenuated
CRC growth in mouse xenograft
models when aliquots of 40 ll
of PBS containing 1 lg of
mature miR-429 or scramble
were directly injected into the
tumor. *P \ 0.05; **P \ 0.01
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123
24 h, we showed that the wound healing extent with miR-
429 mimics treatment significantly slows down that of the
scramble treatment in SW620 cells (Fig. 3a). To analyze if
miR-429 affected the wound healing through inhibiting
Onecut2, we synthesized Onecut2 siRNA and constructed
the pcDNA3.1–Onecut2 expression vector. SW620 cells
were transfected with Onecut2 siRNA and scramble siR-
NA, and found that Onecut2 siRNA inhibited the wound
healing (Fig. 3a); however, re-expression of Onecut2 res-
cued inhibitory effect of miR-429 on cell migration
(Fig. 3b).
Next, we further to detect the effect of miR-429 on cell
invasion by transwell matrigel invasion assay. Overex-
pression of miR-429 or siOnecut2 inhibited the in vitro
invasion potential of SW620 cells, whereas re-expression
of Onecut2 rescued this inhibition (Fig. 3c). The above
Fig. 2 miR-429 targets transcript factor Onecut2 and is inversely
correlated with the mRNA or protein levels of Onecut2 in CRC
tissues. a Luciferase assay on SW620 cells, which were cotransfected
with miR-429 and a luciferase reporter containing the full length of
Onecut2 30-UTR (Luc-wt) or a mutant (Luc-mut) in which the four
nucleotides of the miR-429-binding site were mutated. Luciferase
activities were measured 48-h post transfection. miR-429 markedly
suppressed luciferase activity in Luc-wt reporter constructs. The data
are mean ± SD for separate transfections (n = 6). b Onecut2 mRNA
level was analyzed upon miR-429 or scramble transfection in HT-29,
SW620, and SW480 cells by real-time PCR. All data are shown as
mean ± SD. **P \ 0.01. c miR-429 transfection affects Onecut2
protein levels by Western blot analysis. HT-29, SW620, and SW480
cells were transfected with miR-429 or scramble control. d Represen-
tative expression levels of miR429 and Onecut2 mRNA by real-time
PCR in clinical specimens (n = 50), and the correlation between
miR-429 and Onecut2 was analyzed by Spearman’s correlation test.
e ISH detects the position and expression of miR-429, and IHC
detects the position and expression of Onecut2 in CRC (103 cases)
relative to paracancerous normal tissues (103 cases). Scale bars
100 lm
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data suggested that miR-429 can inhibit the motility and
invasion of CRC cells by targeting Onecut2.
MiR-429 inhibited the EMT induced by TGF-beta
For EMT the most prominent hallmarks are loss of cell
polarity, loss of cell–cell adhesion, and enhanced migration
potential, eventually leading to increased motility and
invasion of cancer cells [1]. The TGF-b is a pleiotropic
cytokine, which drives the EMT mainly by repressing
E-cadherin transcription and disrupting its localization at
the plasma membrane, which influences adherens junctions
[19]. The above data suggest that miR-429 can inhibit the
motility and invasion of CRC cells by targeting Onecut2.
Thus, in this section, we will focus on if miR-429 affects
the TGF-b-induced EMT at different time points. The
results presented in Fig. 4a and b demonstrate that TGF-b
significantly resulted in a cells morphological phenotype of
EMT after 24 h when SW620 or SW480 was treated with
TGF-b, respectively; miR-429 mimics or siOnetcut2
Fig. 2 continued
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inhibited SW620 or SW480 cells to undergo TGF-b-
induced morphological change from a more polygoned,
epithelial-like phenotype to an elongated, spindle-shaped,
mesenchymal phenotype. In contrast, no change in mor-
phology was detected in SW620 or SW480 cells transfec-
ted with the scramble control sequence.
Fig. 3 Effect of miR-429 on cells mobility and invasion by target
Onecut2 in CRC cells. a Wound-healing assay analyzes the effect of
miR-429 or si-Onecut2 on SW620 cells migration. *P \ 0.05.
b Wound-healing assay analyzes the rescued effect of Onecut2
overexpression on inhibitory healing induced by miR-429. *P \ 0.05.
c Matrigel invasion assay analyzes the rescued effect of Onecut2
overexpression on invasion inhibition induced by miR-429.
**P \ 0.01
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miR-429 regulated the expression of EMT-related
transcript factors and genes in CRC cells
EMT is characterized by loss of functional expression of
E-cadherin and other epithelial markers such as cytokera-
tins or ZO-1; and induction of mesenchymal markers,
notably vimentin, N-cadherin, a-smooth muscle actin, etc.
[2]. EMT also involved in other adhesion and cytoskeletal-
related genes such as CD44, MMP2, CTNA1, CTNB1,
ZEB1, ZEB2, Snail, Slug, etc. Thus, we studied in depth
the mechanism of miR-429 inhibiting EMT by targeting
Onecut2. The data indicated that transforming growth
factor TGF-b1 induced the change of the above EMT-
related genes; however, miR-429 or si-Onecut2 rescued the
genes expression alteration induced by TGF-b1 in SW620
cells. Both overexpression of miR-429 and interfering
Onecut2 expression increased the expression of catenin
molecular (E-cadherin, CTNNA1, and CTNNB1) and
fibronectin (FN), and it also decreased the expression of
heterogeneity adhesion molecule CD44, matrix metallo-
proteinase MMP2, Vimentin, and EMT-related transcript
factors Slug, Snail, ZEB2, and Onecut2 (Fig. 5a, b).
Discussion
miR-429 is a member of the miR-200 family, and posi-
tioned on chromosome 1. miR-429 is downregulated in
renal cell carcinoma [3], nasopharyngeal carcinoma [4],
Ehrlich ascites tumor cells [5], gastric cancer [3–6], and
endometrial endometrioid carcinomas [7]. miR-429 and
miR-200c are expressed in the luminal and basal type of
breast cancer in contrast to malignant myoepithelioma,
which revealed significantly lower levels potentially con-
tributing to its mesenchymal phenotype [9].
In this study, we showed that miR-429 was significantly
downregulated in II and III stages CRC cancer tissues
when compared with adjacent normal tissue. We also used
nude mouse xenograft models to confirm that miR-429
could suppress CRC cells tumorigenicity in vivo, sug-
gesting that miR-429 could play a role in CRC
tumorgenesis.
We next explored the possible targets of miR-429 in
CRC cells through different computational algorithms.
Taking into account our previous data that: Onecut2 exis-
ted in the core of the gene networks in colorectal
Fig. 4 The morphology observation that miR-429 or siOnecut2 inhibits EMT induced by TGF-b in SW620 cells (a) and SW480 cells (b)
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carcinoma [24] and miR-429 was as the core of miRNA–
RNA network of CRC network [24]; therefore, in-silico
analysis revealed Onecut2 as a candidate target of miR-
429, which attracted our attention immediately. We
observed a substantial upregulation of Onecut2 protein in
CRC tissues, and Onecut2 protein levels were inversely
correlated with miR-429 levels. Importantly, we showed
that miR-429 negatively regulated Onecut2 expression in
mRNA and protein level in CRC cells, suggesting a role for
miR-429 dysregulation in the pathogenesis of CRC.
The above data suggest that downregulation of miR-429
contribute to CRC carcinogenesis by targeting Onecut2.
Our previous data also indicated that deregulation of miR-
429 was not correlated with the lymphatic metastasis [24];
thus, we speculated that miR-429 may be involved in the
initiation of EMT of CRC by targeting Oncut2. EMT is
involved in both physiological and pathophysiological
processes, whose most prominent hallmarks are loss of cell
polarity, loss of cell–cell adhesion, and enhanced migration
potential, eventually leading to increased motility and
invasiveness of cancer cells [1]. We further to study the
effect of miR-429 on cell migration, invasion, and EMT in
CRC cells. Our data suggested that miR-429 inhibited the
cells migration and invasion and reversed TGF-b-induced
EMT changes in CRC cells. At the same time, interfering
the endogenous Onecut2 also could inhibit the SW620 cell
migration; overexpressed Onecut2 reversed the miR-429-
mediated cell migration and invasion suppression.
TGF-b is a pleiotropic cytokine, which not only inhibits
the cell proliferation, but also promotes the local inva-
siveness through induction of EMT or angiogenesis [2, 17,
18]. TGF-b drives the EMT by influencing adherens
Fig. 5 miR-429 regulates the expression of EMT-related marker
genes by targeting Onecut2 in CRC cells. a miR-429 rescued the
expression alteration of EMT-related marker genes induced by TGF-
b1 in SW620 cells. *P \ 0.05. b si-Onecut2 rescued the expression
alteration of EMT-related marker genes induced by TGF-b1 in
SW620 cells. *P \ 0.05
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junctions either directly by interaction of TGF-b receptors
and protein Par6, or by repressing E-cadherin transcription
[19]. Component of an E-cadherin/catenin adhesion com-
plex composed of at least E-cadherin/CDH1, b-catenin/
CTNNB1, or c-catenin/JUP, and potentially a-catenin/
CTNNA1; the complex is located to adherens junctions
[27]. TFN1, CD44, and MMP2 are all EMT markers genes,
whose aberrant expressions were involved in the EMT of
cancer [28–30]. Our data suggested that miR-429 overex-
pression and Onecut2 siRNA increased the expression of
catenin molecular (E-cadherin, CTNNA1, and CTNNB1)
and fibronectin (FN), and it also decreased the expression
of heterogeneity adhesion molecule CD44 and matrix
metalloproteinase MMP2. Although CTNNB1 gene that
codes for b-catenin can function as an oncogene, its
mutations is a cause which leads to growth of many tumors
and especially CRC [31]; however, our data indicated that
miR-429 increased the expression of CNNB1, one possible
reason is that CNNB1 may be not mutated in SW620 cells.
The best characterized EMT inducers are zinc-finger
transcription factors SNAI1/Snail and SNAI2/Slug, ZEB1/
dEF-1, and ZEB2/SIP1, acting as repressors of E-cadherin
transcription through interaction with conserved E-boxes in
the E-cadherin promoter [3–5]. The previous studies
showed that TGF-b1 induces the expression of ZEB1,
ZEB2, and SLUG, but not SNAI in benign prostatic
hyperplasia epithelial cell line BPH-1 Cells [32]. Our
studies indicated that TGF-b1 could induce ZEB1, ZEB2,
SNAI, and SLUG, miR-429 inhibited the expression of
Onecut2, ZEB1, ZEB2, SNAI, and SLUG; whereas inter-
fering the expression of Onecut2 had the consistent effects
on the above transcript factors with the miR-429
overexpression.
Taken together, our data showed that transcript factor
Onecut2 is involved in the EMT, migration, and invasion of
CRC cells, miR-429 inhibits the initiation of EMT by tar-
gets Onecut2, and Onecut2-mediated EMT-related genes
and transcript activators. In the next study, we will dem-
onstrated the potential mechanism by which miR-429 is
downregulated in colorectal carcinoma, the downregulated
expression of miR-429 may be correlated with the aberrant
regulation of transcript factor or long non-coding RNAs.
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